Elkrief A - Search Results

1

Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France.

Elkrief A, Richard C, Malo J, Cvetkovic L, Florescu M, Blais N, Tehfe M, Messaoudene M, Gagné A, Orain M, Medjebar S, Wan-Chow-Wah D, Joubert P, Labbé C, Ghiringhelli F, Routy B. Elkrief A, et al. J Geriatr Oncol. 2020 Jun;11(5):802-806. doi: 10.1016/j.jgo.2020.01.002. Epub 2020 Jan 14. J Geriatr Oncol. 2020. PMID: 31948904

2

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas.

Elkrief A, Makhnin A, Moses KA, Ahn LS, Preeshagul IR, Iqbal AN, Hayes SA, Plodkowski AJ, Paik PK, Ladanyi M, Kris MG, Riely GJ, Michor F, Yu HA. Elkrief A, et al. Clin Cancer Res. 2023 Apr 14;29(8):1423-1428. doi: 10.1158/1078-0432.CCR-22-3484. Clin Cancer Res. 2023. PMID: 36729110 Free PMC article.

3

The intimate relationship between gut microbiota and cancer immunotherapy.

Elkrief A, Derosa L, Zitvogel L, Kroemer G, Routy B. Elkrief A, et al. Gut Microbes. 2019;10(3):424-428. doi: 10.1080/19490976.2018.1527167. Epub 2018 Oct 19. Gut Microbes. 2019. PMID: 30339501 Free PMC article.

4

Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors.

Elkrief A, El Raichani L, Richard C, Messaoudene M, Belkaid W, Malo J, Belanger K, Miller W, Jamal R, Letarte N, Wong P, Routy B. Elkrief A, et al. Oncoimmunology. 2019 Feb 18;8(4):e1568812. doi: 10.1080/2162402X.2019.1568812. eCollection 2019. Oncoimmunology. 2019. PMID: 30906663 Free PMC article.

5

The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?

Elkrief A, Derosa L, Kroemer G, Zitvogel L, Routy B. Elkrief A, et al. Ann Oncol. 2019 Oct 1;30(10):1572-1579. doi: 10.1093/annonc/mdz206. Ann Oncol. 2019. PMID: 31268133 Free article. Review.

6

Therapeutic landscape of metastatic non-small-cell lung cancer in Canada in 2020.

Elkrief A, Joubert P, Florescu M, Tehfe M, Blais N, Routy B. Elkrief A, et al. Curr Oncol. 2020 Feb;27(1):52-60. doi: 10.3747/co.27.5953. Epub 2020 Feb 1. Curr Oncol. 2020. PMID: 32218661 Free PMC article.

7

Moving towards personalized treatments of immune-related adverse events.

Esfahani K, Elkrief A, Calabrese C, Lapointe R, Hudson M, Routy B, Miller WH Jr, Calabrese L. Esfahani K, et al. Among authors: elkrief a. Nat Rev Clin Oncol. 2020 Aug;17(8):504-515. doi: 10.1038/s41571-020-0352-8. Epub 2020 Apr 3. Nat Rev Clin Oncol. 2020. PMID: 32246128 Review.

8

Erratum: Therapeutic landscape of metastatic non-small-cell lung cancer in Canada in 2020.

Elkrief A, Joubert P, Florescu M, Tehfe M, Blais N, Routy B. Elkrief A, et al. Curr Oncol. 2020 Jun;27(3):e349. doi: 10.3747/co.27.6577. Epub 2020 Jun 1. Curr Oncol. 2020. PMID: 32669946 Free PMC article.

9

The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer.

Hakozaki T, Richard C, Elkrief A, Hosomi Y, Benlaïfaoui M, Mimpen I, Terrisse S, Derosa L, Zitvogel L, Routy B, Okuma Y. Hakozaki T, et al. Among authors: elkrief a. Cancer Immunol Res. 2020 Oct;8(10):1243-1250. doi: 10.1158/2326-6066.CIR-20-0196. Epub 2020 Jul 27. Cancer Immunol Res. 2020. PMID: 32847937

10

Changes in Lung Cancer Treatment as a Result of the Coronavirus Disease 2019 Pandemic.

Elkrief A, Kazandjian S, Bouganim N. Elkrief A, et al. JAMA Oncol. 2020 Nov 1;6(11):1805-1806. doi: 10.1001/jamaoncol.2020.4408. JAMA Oncol. 2020. PMID: 32940638 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters